Sotera Health Company has appointed Karen Flynn as a new independent director to its Board. She most recently served as Interim President of BioModalities at Catalent.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SHC:
